Cardiology

US approves less-invasive heart defibrillator

(AP)—The U.S. Food and Drug Administration says it has approved a first-of-a-kind heart-zapping implant from Boston Scientific that that does not directly touch the heart.

Medications

An old drug finds a new use

Dr. Anglea Wandinger-Ness and Dr. Laurie Hudson were awarded a Provocative Questions grant to investigate the use of R-ketorolac against ovarian cancer. Ketorolac is an NSAID that the FDA approved for human use in 1991. They ...

Oncology & Cancer

Belimumab for lupus erythematosus: Added benefit not proven

Belimumab (trade name Benlysta) has been approved since July 2011 as an add-on therapy for adult patients with the autoimmune disease systemic lupus erythematosus (SLE). This monoclonal antibody is only considered as treatment ...

Alzheimer's disease & dementia

New imaging test aids Alzheimer's diagnosis

In research studies, scientists regularly use positron emission tomography (PET) scans to detect signs of Alzheimer's disease. Now, Washington University physicians at Barnes-Jewish Hospital are the first in Missouri to offer ...

Medications

3-D tumor models improve drug discovery success rate

Imagine millions of cancer cells organized in thousands of small divots. Hit these cells with drugs and when some cells die, you have a candidate for a cancer drug. But a review published this week in the journal Expert Opinion ...

Health

Major medical groups back sweeteners as diet aid

(HealthDay) -- Non-nutritive sweeteners like Splenda, Equal and Sweet'N Low may have a role to play in maintaining or even losing weight, as long as people don't use them as an excuse to treat themselves later with high-calorie ...

page 19 from 24